中农联合(003042) - 2025 Q2 - 季度业绩预告

Shandong Zhongnong United Biotechnology Co., Ltd. 2025 Semi-Annual Performance Forecast Performance Forecast Overview H1 2025 net profit attributable to shareholders is projected at 3.05-3.95 million CNY, marking a significant turnaround from the previous year's loss Key Performance Indicators for H1 2025 Performance Forecast | Indicator | Current Period (2025 H1 Est.) | Prior Year (2024 H1) | | :--- | :--- | :--- | | Net Profit Attributable to Shareholders | Profit: 3.05 million – 3.95 million CNY | Loss: 32.5777 million CNY | | Year-over-Year Growth | 109.36% - 112.12% | - | | Net Profit Excluding Non-Recurring Items | Profit: 1.85 million – 2.75 million CNY | Loss: 35.3477 million CNY | | Year-over-Year Growth | 105.23% - 107.78% | - | | Basic Earnings Per Share | Profit: 0.02 CNY/share – 0.03 CNY/share | Loss: 0.23 CNY/share | Reasons for Performance Change Despite low market prices, the company achieved a turnaround by optimizing operations, expanding markets, adjusting sales strategies, and enhancing cost-efficiency - The core driver for the company's performance improvement is optimized internal operational management, addressing intense external market competition and low product prices[4] - Key initiatives include actively strengthening market expansion, flexibly adjusting sales strategies, comprehensively promoting innovation, and deeply advancing cost reduction and efficiency improvement[4] - These measures directly resulted in a steady increase in product output, sales volume, and operating revenue, ultimately driving the company's operating performance to turn profitable compared to the previous year[4] Other Notes and Risk Warnings This preliminary, unaudited performance forecast is based on internal estimates; final data will be in the 2025 semi-annual report, cautioning investors about risks - The financial data related to this performance forecast has not been audited by certified public accountants[3] - This forecast represents a preliminary estimate by the company's finance department; final data will be based on the officially released 2025 semi-annual report[5] - The company advises investors to exercise caution in decision-making and be aware of investment risks[5]